Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 3.61 is 64% below its 5-year average of 9.94, near the low end of its 5-year range (3.61–19.28).
As of the fiscal period ended Tuesday, June 30, 2026. 61.13% below its 12-month average of 9.28.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 3.61.
QUICK RATIO (ACID-TEST)
3.61
QUICK RATIO (ACID-TEST) AVG TTM
9.28
QUICK RATIO (ACID-TEST) AVG 3Y
9.75
QUICK RATIO (ACID-TEST) AVG 5Y
9.94
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
-61.13%
CURRENT VS 3Y AVG
-62.97%
CURRENT VS 5Y AVG
-63.70%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.35
median of 870 covered companies
CURRENT VS SECTOR MEDIAN
+7.55%
vs the sector median at left
RxSight, Inc.
Market Cap
$192.49M
Quick Ratio (Acid-Test)
3.61
TTM Avg
9.28
3Y Avg
9.75
5Y Avg
9.94
Market Cap
$190.07M
Quick Ratio (Acid-Test)
4.82
TTM Avg
7.13
3Y Avg
7.35
5Y Avg
8.24
Market Cap
$189.11M
Quick Ratio (Acid-Test)
7.90
TTM Avg
9.91
3Y Avg
10.86
5Y Avg
18.34
Market Cap
$197.18M
Quick Ratio (Acid-Test)
12.14
TTM Avg
7.27
3Y Avg
7.16
5Y Avg
7.21
Market Cap
$198.33M
Quick Ratio (Acid-Test)
7.48
TTM Avg
9.04
3Y Avg
6.33
5Y Avg
4.86
Market Cap
$200.96M
Quick Ratio (Acid-Test)
5.26
TTM Avg
3.62
3Y Avg
4.54
5Y Avg
4.95
Market Cap
$182.60M
Quick Ratio (Acid-Test)
14.32
TTM Avg
7.65
3Y Avg
9.22
5Y Avg
9.58
Market Cap
$180.47M
Quick Ratio (Acid-Test)
15.70
TTM Avg
3.42
3Y Avg
4.67
5Y Avg
3.16
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| RxSight, Inc. (RXST) | $192.49M | 3.61 | 9.28 | 9.75 | 9.94 |
| Zentalis Pharmaceuticals, Inc. (ZNTL)vs › | $190.07M | 4.82 | 7.13 | 7.35 | 8.24 |
| Eledon Pharmaceuticals, Inc. (ELDN)vs › | $189.11M | 7.90 | 9.91 | 10.86 | 18.34 |
| Surrozen, Inc. (SRZN)vs › | $197.18M | 12.14 | 7.27 | 7.16 | 7.21 |
| Exagen Inc. (XGN)vs › | $197.87M | 3.18 | 3.08 | 4.43 | 6.31 |
| Cartesian Therapeutics, Inc. (RNAC)vs › | $198.33M | 7.48 | 9.04 | 6.33 | 4.86 |
| Alector, Inc. (ALEC)vs › | $200.96M | 5.26 | 3.62 | 4.54 | 4.95 |
| AN2 Therapeutics, Inc. (ANTX)vs › | $182.60M | 14.32 | 7.65 | 9.22 | 9.58 |
| Canton Strategic Holdings Inc (CNTN)vs › | $180.47M | 15.70 | 3.42 | 4.67 | 3.16 |
| Compass Therapeutics, Inc. (CMPX)vs › | $179.75M | 11.22 | 14.99 | 15.44 | 13.43 |
Quick Ratio
3.61
Excludes inventory
Current Ratio
4.07
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 3.61 |
| 2026-03-31 | 8.93 |
| 2025-12-31 | 9.75 |
| 2025-09-30 | 11.44 |
| 2025-06-30 | 12.70 |
| 2025-03-31 | 11.65 |
| 2024-12-31 | 10.50 |
| 2024-09-30 | 11.71 |
| 2024-06-30 | 13.34 |
| 2024-03-31 | 8.18 |
| 2023-12-31 | 7.22 |
| 2023-09-30 | 7.87 |
| 2023-06-30 | 9.81 |
| 2023-03-31 | 11.40 |
| 2022-12-31 | 6.95 |
| 2022-09-30 | 7.57 |
| 2022-06-30 | 10.64 |
| 2022-03-31 | 14.32 |
| 2021-12-31 | 15.19 |
| 2021-09-30 | 19.28 |
| 2021-06-30 | 6.04 |
| 2021-03-31 | 9.93 |
| 2020-12-31 | 6.31 |
| 2020-09-30 | 0.00 |
| 2020-06-30 | 0.00 |
| 2020-03-31 | 0.00 |
